Results 161 to 170 of about 466,931 (209)

Will Stub1 Be the Next Target for Pulmonary Hypertension Therapy Development? [PDF]

Am J Respir Cell Mol Biol
Shen Y.
europepmc   +1 more source

Northern Pulmonary Hypertension: Personal Experience and Brief History. [PDF]

Pulm Circ
Chernyaev AL.
europepmc   +1 more source

A Novel Role for Platelet-Endothelial Crosstalk in Pulmonary Hypertension. [PDF]

Am J Respir Cell Mol Biol
Hu L, Chen F.
europepmc   +1 more source

The Surgical Management of Chronic Thromboembolic Pulmonary Hypertension. [PDF]

J Clin Med
McGann KC, Wang CC, Trahanas JM, Bommareddi S, Lima B, Ahmad A, Chin CW, Robbins IM, Pugh ME, Hemnes AR, Funke B, Shah AS, Williams AM.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pulmonary hypertension

Drugs of Today, 1998
Pulmonary hypertension can be caused by an increase in pulmonary blood flow, an increase in left-heart impedance or an increase in pulmonary vascular resistance. Although there are many specific causes that have been identified, clinical presentation and natural history are common to all etiologies.
D, Moraes, J, Loscalzo
openaire   +2 more sources